The Role of Ultra-Radical Surgery in the Management of Advanced Ovarian Cancer: State of the Art
The ovarian cancer, also known as “silent killer”, has remained the most lethal gynaecological malignancy. The single independent risk factor linked with improved survival is maximum cytoreductive effort resulting in no macroscopic residual disease. This could be gained through ultra-radical surgery...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Book Chapter |
| Language: | English |
| Published: |
IntechOpen
2021
|
| Subjects: | |
| Online Access: | https://www.intechopen.com/chapters/78061 |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: The Role of Ultra-Radical Surgery in the Management of Advanced Ovarian Cancer: State of the Art
- Combined Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for the Treatment of Advanced Ovarian Cancer
- Perspective Chapter: The Use of Fluorescence in Ovarian Cancer Surgery
- The Role of Chemotherapy in Recurrent Ovarian Cancer
- The Roles of Nanoparticle in the Treatment and Diagnosis of Ovarian Cancer
- Cytoreductive Procedures and HIPEC in the Treatment of Advanced Ovarian Cancer
- Endometriosis-Associated Ovarian Cancer: The Role of Oxidative Stress